BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Singh P, Kairuz D, Arbuthnot P, Bloom K. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach. World J Gastroenterol 2021; 27(23): 3182-3207 [PMID: PMC8218364 DOI: 10.3748/wjg.v27.i23.3182]
URL: https://www.wjgnet.com/1007-9327/full/v27/i23/3182.htm
Number Citing Articles
1
Patricia Gita Naully, Marselina Irasonia Tan, Husna Nugrahapraja, Aluicia Anita Artarini, Reza Aditama, Ernawati Arifin Giri-Rachman, Sheikh Arslan Sehgal. Design of multi-epitope-based therapeutic vaccine candidates from HBc and HBx proteins of hepatitis B virus using reverse vaccinology and immunoinformatics approachesPLOS ONE 2024; 19(12): e0313269 doi: 10.1371/journal.pone.0313269
2
Rachel Matrenec, Claudia E. Oropeza, Eddie Dekoven, Carly Matrenec, Mark Maienschein-Cline, Cecilia S. Chau, Stefan J. Green, Klaus H. Kaestner, Alan McLachlan, Jae U. Jung. Foxa deficiency restricts hepatitis B virus biosynthesis through epigenic silencingJournal of Virology 2024; 98(11) doi: 10.1128/jvi.01371-24
3
Samrita Naidu, Severine Margeridon. Chronic Hepatitis B Virus Persistence: Mechanisms and InsightsCureus 2025;  doi: 10.7759/cureus.78944
4
Liqiong Yang, Tao Zou, Yao Chen, Yueshui Zhao, Xu Wu, Mingxing Li, Fukuan Du, Yu Chen, Zhangang Xiao, Jing Shen. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinomaHepatology International 2022; 16(4): 741 doi: 10.1007/s12072-022-10351-6
5
Patricia Gita Naully, Marselina Irasonia Tan, Agustiningsih Agustiningsih, Caecilia Sukowati, Ernawati Arifin Giri-Rachman. cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis BAnnals of Hepatology 2025; 30(1): 101533 doi: 10.1016/j.aohep.2024.101533
6
Jihua Ren, Shengtao Cheng, Fang Ren, Huiying Gu, Daiqing Wu, Xinyan Yao, Ming Tan, Ailong Huang, Juan Chen. Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNAGenes & Diseases 2025; 12(1): 101215 doi: 10.1016/j.gendis.2024.101215
7
Mark A. Feitelson, Alla Arzumanyan, Ira Spector, Arvin Medhat. Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis BBiomedicines 2022; 10(9): 2210 doi: 10.3390/biomedicines10092210
8
Johannes Bächer, Lena Allweiss, Maura Dandri. SMC5/6-Mediated Transcriptional Regulation of Hepatitis B Virus and Its Therapeutic PotentialViruses 2024; 16(11): 1667 doi: 10.3390/v16111667
9
Nadiia Kasianchuk, Krystyna Dobrowolska, Sofiia Harkava, Andreea Bretcan, Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Robert Flisiak, Piotr Rzymski. Gene-Editing and RNA Interference in Treating Hepatitis B: A ReviewViruses 2023; 15(12): 2395 doi: 10.3390/v15122395
10
Ulrike M. Reiss, Johnny Mahlangu, Tsukasa Ohmori, Margareth C. Ozelo, Alok Srivastava, Lei Zhang. Haemophilia gene therapy—Update on new country initiativesHaemophilia 2022; 28(S4): 61 doi: 10.1111/hae.14512
11
S. Yao, K. Prates, A. Freydenzon, G. Assante, A. F. McRae, M. J. Morris, N. A. Youngson. Liver‐specific deletion of de novo DNA methyltransferases protects against glucose intolerance in high‐fat diet‐fed male miceThe FASEB Journal 2024; 38(10) doi: 10.1096/fj.202301546RR
12
Dylan Kairuz, Prashika Singh, Tiffany Smith, Patrick Arbuthnot, Abdullah Ely, Kristie Bloom. Messenger RNA TherapeuticsRNA Technologies 2022; 13: 157 doi: 10.1007/978-3-031-08415-7_8
13
Mohube B. Maepa, Abdullah Ely, Anna Kramvis, Kristie Bloom, Kubendran Naidoo, Omphile E. Simani, Tongai G. Maponga, Patrick Arbuthnot. Hepatitis B Virus Research in South AfricaViruses 2022; 14(9): 1939 doi: 10.3390/v14091939